These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 31046487)

  • 1. Pathophysiology of systemic sclerosis: current understanding and new insights.
    Cutolo M; Soldano S; Smith V
    Expert Rev Clin Immunol; 2019 Jul; 15(7):753-764. PubMed ID: 31046487
    [No Abstract]   [Full Text] [Related]  

  • 2. Early inflammatory players in cutanous fibrosis.
    Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
    J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis.
    Asano Y
    J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology of systemic sclerosis].
    Allanore Y
    Med Sci (Paris); 2016 Feb; 32(2):183-91. PubMed ID: 26936176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
    Yoshizaki A
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Vessels Contribute to Fibrosis in Systemic Sclerosis.
    Di Benedetto P; Ruscitti P; Liakouli V; Cipriani P; Giacomelli R
    Isr Med Assoc J; 2019 Jul; 21(7):471-474. PubMed ID: 31507123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc).
    Valentini G
    Autoimmun Rev; 2015 Mar; 14(3):210-3. PubMed ID: 25461837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early systemic sclerosis-opportunities for treatment.
    Sakkas LI; Simopoulou T; Katsiari C; Bogdanos D; Chikanza IC
    Clin Rheumatol; 2015 Aug; 34(8):1327-31. PubMed ID: 25711876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
    Coelho Horimoto AM; da Costa IP
    Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raynaud's phenomenon.
    Hughes M; Herrick AL
    Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):112-32. PubMed ID: 27421220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of toll-like receptors in systemic sclerosis.
    Ciechomska M; Cant R; Finnigan J; van Laar JM; O'Reilly S
    Expert Rev Mol Med; 2013 Aug; 15():e9. PubMed ID: 23985302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis.
    Allanore Y; Simms R; Distler O; Trojanowska M; Pope J; Denton CP; Varga J
    Nat Rev Dis Primers; 2015 Apr; 1():15002. PubMed ID: 27189141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunopathological disturbances in systemic sclerosis].
    Gindzieńska-Sieśkiewicz E; Klimiuk PA; Kowal-Bielecka O; Sierakowski S
    Pol Merkur Lekarski; 2005 Dec; 19(114):800-3. PubMed ID: 16521427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
    Hasegawa M
    J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Concepts on the Pathogenesis of Systemic Sclerosis.
    Truchetet ME; Brembilla NC; Chizzolini C
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):262-283. PubMed ID: 34487318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of Systemic Sclerosis.
    Pattanaik D; Brown M; Postlethwaite BC; Postlethwaite AE
    Front Immunol; 2015; 6():272. PubMed ID: 26106387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine.
    Lescoat A; Varga J; Matucci-Cerinic M; Khanna D
    Expert Opin Investig Drugs; 2021 Jun; 30(6):635-652. PubMed ID: 33909517
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis.
    Manetti M; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
    J Cell Mol Med; 2010 Jun; 14(6A):1241-54. PubMed ID: 20132409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.